web analytics
13.3 C
Munich
Sunday, September 25, 2022

Boon Industries, Inc (OTCMKTS: BNOW) Major Run Northbound as Co Reports its New Processing Facility is Up and Running

Boon Industries, Inc (OTCMKTS: BNOW) is making an explosive move northbound after the Company announced its production facility is up and running with a $78M annual capacity. This escalation in sales validates and aligns with Boon Industries’ belief that the cGMP status stimulates and expedites ongoing anchor level relationships. Boon’s customer acquisition costs and ratio to establishing new customers is 1:2. The customers are repeat and will purchase an estimated $.50 per sq ft of BioDox. The farms range from 10,000 sq. ft. to 10,000 acres. CEO Justin Gonzalez stated: “The new facility will produce over one thousand gallons of BioDox or Diox+ per day, which represents revenue of approximately $300,000 per day. This allows for an annual revenue to meet demand of approximately $78M before expansion would be required.” 

BNOW traded like a rockstar on Thursday doing just under $8 million in dollar volume on 1.3 billion shares traded and showing a gain of +714.29% on the day. The stock has managed to attract a massive new following of investors here and serves as an example of what can happen on the OTC and possibly a harbinger of a coming red hot penny stock market. Boon’s flagship is its DiOx+, a Chlorine Dioxide Disinfectant Sterilizer. Chlorine Dioxide has been approved by OSHA, FDA, EPA, CDC, USDA, and DOT. DiOx+ kills 99.9999% of harmful pathogens without dangerous toxic exposure to the user or the environment. The proprietary chemical formulas and processes behind DiOx+ make it ideal for sterilization of mission critical, high value medical equipment and disinfecting air and surfaces in laboratory and hospital environments.  

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Boon Industries, Inc (OTCMKTS: BNOW) operating out of Grass Valley, California is an innovative bioscience company delivering environmentally safe products to benefit people and the planet. At the core of Boon Industries is a passion to create revolutionary solutions to today’s toughest health and environmental challenges. Boon’s dedicated team has years of experience, creating, manufacturing, and marketing proprietary chemical solutions to a global market. The Company is committed to doing right by people and the planet by providing environmentally safe products. Boon is led by President, Justin Gonzalez; a high-level executive who has spent decades working in executive positions in manufacturing and marketing chemical solutions for the global market. Mr. Gonzalez is also the founder and CEO of multiple companies that have successfully solved complex health and environmental challenges in sanitization, water treatment, and oil & gas industries. 

Boon’s flagship is its DiOx+, a Chlorine Dioxide Disinfectant Sterilizer. Chlorine Dioxide has been approved by OSHA, FDA, EPA, CDC, USDA, and DOT. DiOx+ kills 99.9999% of harmful pathogens without dangerous toxic exposure to the user or the environment. The proprietary chemical formulas and processes behind DiOx+ make it ideal for sterilization of mission critical, high value medical equipment and disinfecting air and surfaces in laboratory and hospital environments. DiOx+ helps protect agricultural crops from disease, is used in water treatment plants, and helps reduce operational costs in warehousing, distribution centers and ecommerce support facilities. The introduction of DiOx+ to the U.S. market follows 10+ years of Chlorine Dioxide usage in global markets driven by Boon’s CEO Justin Gonzalez. DiOx+ delivers on Boon’s promise to provide the most effective, affordable solutions without sacrificing health and safety. DiOx+ is produced at Boon’s manufacturing facility and corporate headquarters in Grass Valley, California. 

To Find out the inside Scoop on BNOW Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

BNOW

Earlier this year the Company launched its new BIODOX brand product line; a proprietary form of activated chlorine dioxide targeted specifically for agricultural applications. Boon’s breakthrough formula now makes this solution available to new market segments across the spectrum of food production, from farmers to food distributors, ensuring food safety without compromise. The USDA has deemed chlorine dioxide appropriate for use in organic crop production, as an algicide, disinfectant and sterilizer. Chlorine dioxide is often referred to as the “Ideal Disinfectant” because it is effective against the most resistant pathogens, yet safe for use directly on food. According to Market Analysis and Insights, in its report ‘Agricultural Disinfectant Market in 2021,’ the worldwide Market for Agricultural Disinfectant is projected to reach USD $2.1B by 2026, from USD $1.6B in 2020. 

Boon skyrocketed after the Company announced its production facility is up and running with a $78M annual capacity. This escalation in sales validates and aligns with Boon Industries’ belief that the cGMP status stimulates and expedites ongoing anchor level relationships. Boon’s customer acquisition costs and ratio to establishing new customers is 1:2. The customers are repeat and will purchase an estimated $.50 per sq ft of BioDox. The farms range from 10,000 sq. ft. to 10,000 acres. 

CEO Justin Gonzalez stated: “The new facility will produce over one thousand gallons of BioDox or Diox+ per day, which represents revenue of approximately $300,000 per day. This allows for an annual revenue to meet demand of approximately $78M before expansion would be required.  BioDox is bottled in a concentrated formula that is sold by the quart for $89 or by the gallon for $229. The agriculture markets allow Boon to generate sales as a 25(b) product while waiting for EPA approval for other applications, and Boon is currently developing sales in these markets. We believe our current success in the agriculture industry will be relative to the pending EPA compliant industries such as medical, hospitality and warehousing that as the Company accomplishes these compliance milestones, we will continue to see an increase of revenue from larger distributors for our products as we expand into new markets.” 

For More on BNOW Subscribe Right Now!

BNOW is making an explosive move northbound after the Company announced its production facility is up and running with a $78M annual capacity. This escalation in sales validates and aligns with Boon Industries’ belief that the cGMP status stimulates and expedites ongoing anchor level relationships. Boon’s customer acquisition costs and ratio to establishing new customers is 1:2. The customers are repeat and will purchase an estimated $.50 per sq ft of BioDox. The farms range from 10,000 sq. ft. to 10,000 acres. CEO Justin Gonzalez stated: “The new facility will produce over one thousand gallons of BioDox or Diox+ per day, which represents revenue of approximately $300,000 per day. This allows for an annual revenue to meet demand of approximately $78M before expansion would be required.” BNOW traded like a rockstar on Thursday doing just under $8 million in dollar volume and showing a gain of +714.29% on the day. The stock has managed to attract a massive new following of investors here and serves as an example of what can happen on the OTC and possibly a harbinger of a coming red hot penny stock market. Boon’s flagship is its DiOx+, a Chlorine Dioxide Disinfectant Sterilizer. Chlorine Dioxide has been approved by OSHA, FDA, EPA, CDC, USDA, and DOT. DiOx+ kills 99.9999% of harmful pathogens without dangerous toxic exposure to the user or the environment. The proprietary chemical formulas and processes behind DiOx+ make it ideal for sterilization of mission critical, high value medical equipment and disinfecting air and surfaces in laboratory and hospital environments. We will be updating BNOW as events unfold so make sure you are subscribed to Microcapdaily so you know what is going on with BNOW.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in BNOW either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.